Guergana Kirilova Savova, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 58 | 2024 | 1198 | 7.370 |
Why?
|
Electronic Health Records | 45 | 2023 | 4863 | 3.170 |
Why?
|
Information Storage and Retrieval | 17 | 2023 | 831 | 2.350 |
Why?
|
Data Mining | 14 | 2019 | 560 | 1.790 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 455 | 1.560 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1271 | 1.490 |
Why?
|
Vocabulary, Controlled | 9 | 2014 | 170 | 1.170 |
Why?
|
Algorithms | 30 | 2021 | 14066 | 1.000 |
Why?
|
Semantics | 11 | 2019 | 609 | 0.970 |
Why?
|
Narration | 6 | 2013 | 223 | 0.910 |
Why?
|
Linguistics | 4 | 2013 | 110 | 0.890 |
Why?
|
Computer Systems | 3 | 2017 | 468 | 0.660 |
Why?
|
Disease | 2 | 2015 | 674 | 0.660 |
Why?
|
Medical Records Systems, Computerized | 6 | 2013 | 1195 | 0.620 |
Why?
|
Classification | 2 | 2009 | 128 | 0.600 |
Why?
|
APACHE | 1 | 2017 | 268 | 0.530 |
Why?
|
Artificial Intelligence | 11 | 2025 | 2662 | 0.520 |
Why?
|
Software | 6 | 2023 | 4463 | 0.490 |
Why?
|
Neoplasms | 11 | 2024 | 22344 | 0.480 |
Why?
|
Radiation Oncology | 1 | 2021 | 568 | 0.470 |
Why?
|
Medical Informatics | 5 | 2017 | 743 | 0.440 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1023 | 0.440 |
Why?
|
Anatomy | 1 | 2013 | 126 | 0.380 |
Why?
|
Guidelines as Topic | 2 | 2025 | 1394 | 0.380 |
Why?
|
Pattern Recognition, Automated | 3 | 2013 | 979 | 0.360 |
Why?
|
Colitis, Ulcerative | 7 | 2019 | 1912 | 0.360 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
Crohn Disease | 7 | 2019 | 2281 | 0.350 |
Why?
|
Search Engine | 1 | 2011 | 142 | 0.350 |
Why?
|
Basilar Artery | 2 | 2021 | 207 | 0.330 |
Why?
|
Arthritis, Rheumatoid | 3 | 2015 | 3743 | 0.310 |
Why?
|
Methotrexate | 1 | 2014 | 1719 | 0.290 |
Why?
|
Medical Oncology | 1 | 2019 | 2339 | 0.280 |
Why?
|
Language | 2 | 2024 | 1550 | 0.270 |
Why?
|
Pharmacogenetics | 1 | 2011 | 682 | 0.270 |
Why?
|
Phenotype | 10 | 2019 | 16716 | 0.260 |
Why?
|
Circle of Willis | 3 | 2021 | 76 | 0.260 |
Why?
|
Humans | 98 | 2025 | 766117 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9378 | 0.250 |
Why?
|
Smoking | 3 | 2017 | 9082 | 0.240 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1263 | 0.230 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2011 | 1535 | 0.210 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1084 | 0.200 |
Why?
|
Esophagitis | 1 | 2023 | 163 | 0.190 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4213 | 0.190 |
Why?
|
Breast Neoplasms | 3 | 2014 | 21074 | 0.190 |
Why?
|
Systematized Nomenclature of Medicine | 2 | 2014 | 35 | 0.180 |
Why?
|
Time | 2 | 2015 | 549 | 0.180 |
Why?
|
Medical Informatics Applications | 2 | 2013 | 180 | 0.180 |
Why?
|
Reference Standards | 3 | 2014 | 1011 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 271 | 0.170 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15882 | 0.160 |
Why?
|
Current Procedural Terminology | 1 | 2020 | 101 | 0.160 |
Why?
|
Peripheral Arterial Disease | 1 | 2010 | 1306 | 0.160 |
Why?
|
Disabled Persons | 2 | 2007 | 1208 | 0.160 |
Why?
|
Health Facilities | 1 | 2023 | 578 | 0.150 |
Why?
|
Ecosystem | 1 | 2021 | 489 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 174 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.130 |
Why?
|
Disease Progression | 2 | 2013 | 13616 | 0.130 |
Why?
|
Clinical Coding | 2 | 2015 | 187 | 0.130 |
Why?
|
Unified Medical Language System | 2 | 2014 | 88 | 0.130 |
Why?
|
Female | 40 | 2024 | 396233 | 0.130 |
Why?
|
Nursing Care | 2 | 2007 | 66 | 0.130 |
Why?
|
Knowledge Bases | 1 | 2016 | 96 | 0.120 |
Why?
|
Activities of Daily Living | 1 | 2005 | 2419 | 0.120 |
Why?
|
Prostate | 1 | 2023 | 1758 | 0.120 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.120 |
Why?
|
Terminology as Topic | 5 | 2013 | 1536 | 0.120 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2744 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20137 | 0.120 |
Why?
|
Magnesium | 1 | 2018 | 815 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4342 | 0.120 |
Why?
|
Gastrointestinal Agents | 2 | 2016 | 511 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 938 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Medical Informatics Computing | 1 | 2013 | 23 | 0.110 |
Why?
|
Male | 34 | 2024 | 363935 | 0.110 |
Why?
|
Ownership | 1 | 2015 | 338 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1659 | 0.100 |
Why?
|
Models, Theoretical | 3 | 2016 | 3561 | 0.100 |
Why?
|
Logistic Models | 8 | 2019 | 13273 | 0.100 |
Why?
|
Case-Control Studies | 9 | 2021 | 22228 | 0.100 |
Why?
|
Confidentiality | 2 | 2013 | 607 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2741 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1813 | 0.090 |
Why?
|
Medical Records | 5 | 2020 | 1408 | 0.090 |
Why?
|
Nursing Records | 2 | 2008 | 30 | 0.090 |
Why?
|
Health | 2 | 2005 | 397 | 0.090 |
Why?
|
Documentation | 2 | 2008 | 911 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1811 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 2 | 2011 | 1177 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2013 | 3712 | 0.080 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2689 | 0.080 |
Why?
|
Warfarin | 1 | 2018 | 1494 | 0.080 |
Why?
|
Middle Aged | 23 | 2024 | 223083 | 0.080 |
Why?
|
Registries | 2 | 2023 | 8347 | 0.080 |
Why?
|
Psychology | 1 | 2011 | 353 | 0.080 |
Why?
|
Information Systems | 1 | 2011 | 400 | 0.080 |
Why?
|
Methods | 1 | 2009 | 1061 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 331 | 0.080 |
Why?
|
Computational Biology | 2 | 2016 | 3565 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1604 | 0.080 |
Why?
|
Radiology Information Systems | 2 | 2013 | 535 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1804 | 0.080 |
Why?
|
Aged | 18 | 2024 | 171219 | 0.080 |
Why?
|
Risk Factors | 14 | 2024 | 74857 | 0.080 |
Why?
|
Nursing Diagnosis | 2 | 2008 | 16 | 0.070 |
Why?
|
Biomedical Research | 5 | 2024 | 3458 | 0.070 |
Why?
|
Aromatase Inhibitors | 1 | 2011 | 518 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 489 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14645 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2019 | 2431 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 964 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3135 | 0.070 |
Why?
|
Information Services | 1 | 2008 | 240 | 0.070 |
Why?
|
Child | 5 | 2023 | 80573 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2084 | 0.060 |
Why?
|
Age Factors | 3 | 2021 | 18386 | 0.060 |
Why?
|
ROC Curve | 1 | 2013 | 3614 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12061 | 0.060 |
Why?
|
Cohort Studies | 6 | 2020 | 41684 | 0.060 |
Why?
|
Calcium | 1 | 2018 | 5770 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3107 | 0.060 |
Why?
|
Adult | 18 | 2024 | 223139 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3283 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4044 | 0.060 |
Why?
|
Research Design | 3 | 2025 | 6206 | 0.060 |
Why?
|
Information Dissemination | 1 | 2012 | 1142 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1348 | 0.060 |
Why?
|
Nursing | 1 | 2003 | 35 | 0.050 |
Why?
|
Minnesota | 3 | 2010 | 339 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2013 | 1380 | 0.050 |
Why?
|
Rheumatic Diseases | 1 | 2010 | 657 | 0.050 |
Why?
|
Hospitalization | 2 | 2013 | 10811 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 4044 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4857 | 0.050 |
Why?
|
Silver | 1 | 2023 | 118 | 0.050 |
Why?
|
Child, Preschool | 4 | 2020 | 42511 | 0.050 |
Why?
|
Computer Simulation | 2 | 2013 | 6254 | 0.050 |
Why?
|
Databases, Factual | 4 | 2015 | 8062 | 0.050 |
Why?
|
Genomics | 3 | 2016 | 5926 | 0.050 |
Why?
|
Odds Ratio | 3 | 2018 | 9657 | 0.050 |
Why?
|
Informatics | 1 | 2021 | 72 | 0.050 |
Why?
|
Workload | 1 | 2007 | 849 | 0.050 |
Why?
|
Learning | 1 | 2010 | 1755 | 0.050 |
Why?
|
Pathology, Surgical | 2 | 2013 | 146 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2011 | 2006 | 0.040 |
Why?
|
Delphi Technique | 1 | 2025 | 893 | 0.040 |
Why?
|
International Classification of Diseases | 2 | 2016 | 934 | 0.040 |
Why?
|
Sample Size | 1 | 2023 | 843 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2005 | 1824 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1973 | 0.040 |
Why?
|
Prognosis | 5 | 2025 | 29912 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3272 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2024 | 81565 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5889 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 649 | 0.040 |
Why?
|
Self Care | 1 | 2005 | 800 | 0.040 |
Why?
|
Technology | 1 | 2021 | 296 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1715 | 0.040 |
Why?
|
Data Collection | 1 | 2008 | 3318 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7559 | 0.040 |
Why?
|
Telemedicine | 1 | 2016 | 3108 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 3212 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2003 | 407 | 0.040 |
Why?
|
Risk | 2 | 2020 | 9599 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Social Environment | 1 | 2023 | 1010 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 360 | 0.040 |
Why?
|
Checklist | 1 | 2025 | 841 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9445 | 0.040 |
Why?
|
Italy | 1 | 2019 | 851 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2017 | 348 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2003 | 2351 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 13028 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 600 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2714 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6544 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2260 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 561 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2018 | 597 | 0.030 |
Why?
|
Pilot Projects | 2 | 2006 | 8724 | 0.030 |
Why?
|
United States | 5 | 2019 | 72920 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2017 | 498 | 0.030 |
Why?
|
Comorbidity | 3 | 2016 | 10579 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 8924 | 0.030 |
Why?
|
Research | 1 | 2021 | 1975 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39243 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 862 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1384 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2006 | 3798 | 0.020 |
Why?
|
Pennsylvania | 1 | 2013 | 615 | 0.020 |
Why?
|
Computer Security | 1 | 2013 | 261 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 391 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12803 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11859 | 0.020 |
Why?
|
Database Management Systems | 1 | 2012 | 263 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 770 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1756 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15808 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6324 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54812 | 0.020 |
Why?
|
Technology Assessment, Biomedical | 1 | 2012 | 312 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2010 | 299 | 0.020 |
Why?
|
Nursing Evaluation Research | 1 | 2008 | 25 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2010 | 286 | 0.020 |
Why?
|
Models, Nursing | 1 | 2008 | 47 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2008 | 120 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2395 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2008 | 107 | 0.020 |
Why?
|
Software Design | 1 | 2008 | 173 | 0.020 |
Why?
|
Nursing Process | 1 | 2007 | 17 | 0.020 |
Why?
|
Forms and Records Control | 1 | 2008 | 158 | 0.020 |
Why?
|
Nursing Research | 1 | 2008 | 79 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2520 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 677 | 0.020 |
Why?
|
Decision Trees | 1 | 2008 | 509 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1805 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2353 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10737 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2611 | 0.020 |
Why?
|
Heart Diseases | 1 | 2019 | 2818 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8494 | 0.020 |
Why?
|
Nursing Informatics | 1 | 2006 | 46 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7843 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4399 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1512 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 1850 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3249 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2782 | 0.010 |
Why?
|
Time Factors | 2 | 2018 | 40108 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2008 | 1407 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36548 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13468 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59515 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10614 | 0.010 |
Why?
|
Internet | 1 | 2010 | 3107 | 0.010 |
Why?
|
Population Surveillance | 1 | 2008 | 2596 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24276 | 0.010 |
Why?
|
Radiology | 1 | 2010 | 2105 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5300 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36427 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26290 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88819 | 0.010 |
Why?
|
Health Status | 1 | 2003 | 4086 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59868 | 0.000 |
Why?
|
Quality of Health Care | 1 | 2003 | 4306 | 0.000 |
Why?
|